Site Selections for Tuberculosis Clinical Trials
Authored by  Janis Brix, CEO Wigwam With over 25 years of experience as a CRO and expertise in TB clinical research, Dokumeds has an elaborate network with key stakeholders and clinical sites in TB burden countries and in-depth knowledge of their regulatory framework. The 15 years of dedicated work and experience have enabled Dokumeds to
[ Read More ]